Pfizer pays $179m for Brisbane company behind smartphone app that claims to diagnose COVID
Recent studies had shown the app had a 92 per cent success rate in diagnosing the virus among symptomatic patients, but more clinical trials were needed for it to gain regulatory approval.
ABC News ·